Tagged with A

Merck Sharp & Dohme Limited (MSD) You were previously managing the Merck/Schering-Plough joint venture in the US, and arrived in the UK 2 years ago. What did you set out for yourself as head of the UK operations? As General Manager of the Merck/Schering-Plough Joint Venture in the US, I was responsible for the commercial operations…

Shire International Licensing BV Netherlands Shire has many offices in America, Europe, as well as in Singapore, in Japan and in Australia. The group has a vast global network and a strong presence in these four continents. What is the strategic role that Shire Netherlands plays and how does this role fit into the group’s…

Herbal Science Herbal Science started in 1985 as team of two pharmacists and now represents a large 200-person operation. What have been the main challenges for the company in this transformation and what is it most proud of? Obviously getting new business and maintaining our existing relationships has been very important for…

AstraZeneca UK AstraZeneca reported decrease in its global revenue for the first half of 2011 mostly due to adverse market conditions in the US. In this context, how has the company been performing in its home market and what will be driving your growth in the UK? Our financial results are in…

Promega Netherlands Promega is a truly global company with a vast international presence. What would you say is the strategic importance that the Benelux affiliate has assumed within Promega’s global network? Promega Benelux is actually the first branch office that was established outside of the US, so the company’s experience in bringing…

Association of the British Pharmaceutical Industry (ABPI) Taking a look at a key achievement of the ABPI in recent years, we recognize the role you played in negotiating the revised PPRS that was put in place last year. How did the latest revision contribute to taking the research-based industry forward and what has been the impact of…

Office for the Strategic Coordination of Health Research (OSCHR) It are exciting times for the UK, with the public healthcare system undergoing so many changes. The Office of Life Sciences (OLS) and the Therapeutic Capability Clusters are just some examples of the new way forward. According to you, what are the factors that drove Government to pursue such drastic…

British Generic Manufacturers Association (BGMA) Together with Germany, the UK the highest generic penetration rate in Europe. Since you have been with the association since 1995 and obviously saw the great emergence of the generic medicines, can you please explain the success of generic medicines in the UK? The important aspect about the UK, which…

Association of the British Pharmaceutical Industry (ABPI) What are the priorities on your agenda as the new head of ABPI considering the successes and difficulties the association has experienced in the past? If you look at the recent history of the pharmaceutical industry in the UK, perhaps one of the areas that we have been most successful…

Proprietary Association of Great Britain (PAGB) Thank you for having us today! You have been chief executive of the Association since 1990 and obviously observed the evolution of the OTC market from close by. From your experience, can you please explain our readers how you have seen the OTC market evolving here in the UK? From…

Medichem (Malta) Medichem began production at its plant in Malta in 2006. Can you give us a brief overview of the facilities, and of the importance of the subsidiary to Corporación Medichem as a group? Medichem was set up as a state-of-the-art facility for the manufacture of active pharmaceutical ingredients (APIs) in…

Malaysian Pharmaceutical Society (MPS) The society started at the beginning of the 20th century with the combination of the Penang Pharmaceutical Association and the Straits Pharmaceutical Association. Have there been significant shifts in the society’s objectives and what are its priorities today? For a long time, pharmacy has been a non subject. There was…